CClinicalTrials.gg
Status unknownNCT03554811Updated Aug 20, 2021

Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling in the Intensive Care Unit

An interventional study of Functional electrical stimulation assisted supine cycling (FESC) and Conventional early exercise and mobility interventions in ICU Acquired Weakness, sponsored by Fresno Community Hospital and Medical Center. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-20.

Sponsored by Fresno Community Hospital and Medical Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Critically ill patients in the intensive care unit are known to lose muscle mass and function at a rapid rate. Currently, there is a global recognition and shift in the ICU culture to reduce sedation and encourage exercise and mobilization early during the ICU stay. Functional stimulation assisted supine cycling can be applied to patients in the bed and does not require patient participation. This study seeks to evaluate the effect of conventional exercise and early mobilization in combination with functional stimulation assisted supine cycling applied early during the ICU on muscle mass, strength, and physical function, as well as patient-reported disability as compared to conventional exercise and early mobilization alone.

02

Conditions studied

  • ICU Acquired Weakness
03

In context

Lead sponsor

Fresno Community Hospital and Medical Center is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≥ 18 years of age
  • Admitted to the ICU with a predicted ICU length of stay ≥ 4 days
  • Expected to survive the ICU stay
  • Expected to receive mechanical ventilation > 48 hours
  • Able to perform physical outcome measures pre-morbidly (with or without an assisted device)

Exclusion criteria

Exclusion Criteria:

  • Proven or suspected neuromuscular weakness affecting the legs (eg- stroke or Guillain-Barré syndrome)
  • Lower limb amputation(s)
  • Assessed by medical staff as approaching imminent death or withdrawal of medical treatment within 36 hours
  • Pregnancy
  • Body mass index > 40
  • Presence of external fixator or superficial metal in lower limb
  • Open wounds or skin abrasions at electrode application points
  • Presence of pacemaker or implanted defibrillator
  • Transferred from another ICU after >48 hours of consecutive mechanical ventilation
  • Lower limb malignancy
  • Pre-existing intellectual disability or cognitive impairment limiting the ability to accurately follow instructions
  • Body habitus unable to fit the bike
  • Palliative goals of care
  • Unable to participate in FESC within 48 hours of ICU admission due to logistic reasons or due to failure in daily screening for participation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Functional electrical stimulation assisted supine cycling

    Patients will start functional electrical stimulation assisted supine cycling (FESC) within 48 hours of ICU admission and will undergo up to 1 hour of supine cycling daily, 5 days per week for 28 days, or until discharge from ICU.

    Device: Functional electrical stimulation assisted supine cycling (FESC) · Other: Conventional early exercise and mobility interventions

  • Active comparator
    Conventional early exercise and mobility interventions

    Patients will undergo standard ICU exercise and mobility interventions.

    Other: Conventional early exercise and mobility interventions

Interventions

  • DeviceFunctional electrical stimulation assisted supine cycling (FESC)

    A supine cycle ergometer attached to a six-channel stimulator will be used for FESC. Surface electrodes will be applied to the hamstrings, quadriceps, and calf muscles on both legs. Muscles will be stimulated at specific stages throughout the cycling phase. Each session will start with a 1 minute motor-driven passive cycling warm-up at a rate of 20 revolutions per minute. Patients will continue with passive, active-assisted, or active cycling, according to their level of participation. If the patients stop cycling actively, the ergometer will revert to passive cycling.

  • OtherConventional early exercise and mobility interventions

    These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.

06

What researchers measure

Primary outcomes

  1. Percent change of rectus femoris cross-sectional area

    Ultrasound measurements will be done with patients in supine position with their leg in passive extension and neutral rotation.

    Time frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

Secondary outcomes

  1. Diaphragm muscle thickness

    Thickness will be measured by ultrasound at the zone of apposition during inspiration or expiration using the intercostal approach.

    Time frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

  2. Muscle strength

    Muscle strength will be assessed using the Medical Research Council Scale. This muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle. Weaker muscles will range from 0-3 and stronger muscles will receive grades 4 or 5.

    Time frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge

  3. Muscle strength

    Muscle strength will be assessed using hand-held dynamometry

    Time frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge

  4. Physical function

    Physical function will be assessed using the physical function in ICU (PFIT) test

    Time frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

  5. Physical function

    Physical function will be assessed using the functional status score in the ICU (FSS-ICU). This score consists of 3 pre-ambulation categories (rolling; supine to sit transfer; and unsupported sitting) and 2 ambulation categories (sit to stand transfers; ambulation). Each category is scored from 1 (total dependent assistance) to 7 (complete independence) with a total score range of 0-35 (0: unable to perform a task due to physical limitations or medical status).

    Time frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

  6. Physical function

    Physical function will be assessed using the short physical performance battery (SPPB)

    Time frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

  7. Physical function

    Physical function will be assessed using the six-minute walk test (6MWT)

    Time frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

  8. Quality of life

    Quality of life will be measured using the 36-item Short Health Survey (SF-36), which assess eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each item is scored on a 0-100 scale and items in the same category are averaged together to create the 8 scale scores, with 0 being the lowest score and 100 being the highest for each category.

    Time frame: At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge

  9. Cognition

    Cognition will be assessed using the Montreal Cognitive Assessment (MoCA).

    Time frame: At hospital discharge (an average of 15 days after admission)

  10. Hospital length of stay

    The total hospital length of stay for this admission will be calculated.

    Time frame: Through hospital discharge, an average of 15 days

  11. ICU length of stay

    The total ICU length of stay for this admission will be calculated.

    Time frame: Through ICU discharge, an average of 11 days

  12. Duration of mechanical ventilation

    The total length of time on mechanical ventilation

    Time frame: Through discontinuation of mechanical ventilation, an average of 10 days

07

Study locations

1 of 1 sites recruiting
  • Community Regional Medical Center
    Fresno, California 93721, United States
    • Paul Smith · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03554811
Lead sponsor
Fresno Community Hospital and Medical Center
Collaborators
Western University of Health Sciences
Responsible party
Sponsor
First posted
Jun 13, 2018
Start date
Jan 1, 2020
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Aug 20, 2021

Study contacts

Rachel Dirks, PhD
Contact
rdirks@communitymedical.org
559-459-4029
Paul D Smith, PT, DPT
principal investigator · Community Medical Centers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Fresno Community Hospital and Medical Center

Start the discussion